Ryaltris Approval Status
FDA Approved: No
Brand name: Ryaltris
Generic name: mometasone furoate and olopatadine hydrochloride
Dosage form: Nasal Spray
Company: Glenmark Pharmaceuticals Inc.
Treatment for: Allergic Rhinitis
Ryaltris (mometasone and olopatadine) is an investigational steroid and antihistamine fixed-dose combination nasal spray in development as a treatment for seasonal allergic rhinitis (SAR) in patients 12 years of age and older.
Development Status and FDA Approval Process for Ryaltris
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.